SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

43 hedge funds and large institutions have $67.3M invested in Sinovac Biotech, Ltd in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 21 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $

43% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 21

Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$76K
Puts
$85K
Net Calls
Net Calls Change

Top Buyers

1
+$682K
2
+$607K
3
+$204K
4
FIM
Freedom Investment Management
Connecticut
+$182K
5
CS
Credit Suisse
Switzerland
+$47.9K

Top Sellers

1
-$469K
2
-$410K
3
-$317K
4
Invesco
Invesco
Georgia
-$300K
5
GCP
GSA Capital Partners
United Kingdom
-$270K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$78K
27
$75K
28
$69K
29
$61K
30
$57K
31
$57K
32
$46K
33
$28K
34
$24.1K
35
$19K
36
$9K
37
$8K
38
$5K
39
$5K
40
$3K
41
$3K
42
$2K
43
$1K
44
–
45
–
46
–
47
–
48
–
1
2